Clinical Trials
8
Active:0
Completed:6
Trial Phases
3 Phases
Early Phase 1:1
Phase 1:1
Not Applicable:6
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Not Applicable
6 (75.0%)Early Phase 1
1 (12.5%)Phase 1
1 (12.5%)Evaluating the Efficacy of OCM™ (Omeza® Complete Matrix) in the Treatment of Diabetic Foot Ulcers
Not Applicable
Not yet recruiting
- Conditions
- Diabetic Foot Ulcer
- First Posted Date
- 2025-09-09
- Last Posted Date
- 2025-09-15
- Lead Sponsor
- Omeza, LLC
- Target Recruit Count
- 130
- Registration Number
- NCT07161830
Omeza Combination Therapy for the Management and Treatment of Chronic Cutaneous Wounds/Ulcers of Multiple Etiologies
Early Phase 1
Completed
- Conditions
- Non-Healing Ulcer of SkinNon-healing Wound
- First Posted Date
- 2023-06-27
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- Omeza, LLC
- Target Recruit Count
- 111
- Registration Number
- NCT05921292
- Locations
- 🇺🇸
Christus St. Vincent, Santa Fe, New Mexico, United States
Omeza Products in Combination With Standard of Care for the Treatment of Diabetic Foot Ulcers
Phase 1
Completed
- Conditions
- Diabetic Foot Ulcers
- First Posted Date
- 2022-06-14
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- Omeza, LLC
- Target Recruit Count
- 25
- Registration Number
- NCT05417425
- Locations
- 🇺🇸
Jobst Vascular Institute, Toledo, Ohio, United States
Omeza Combination Therapy With Standard of Care to Standard of Care Alone for Chronic Venous Leg Ulcers
Not Applicable
Completed
- Conditions
- Venous Leg Ulcer
- First Posted Date
- 2022-03-22
- Last Posted Date
- 2024-06-06
- Lead Sponsor
- Omeza, LLC
- Target Recruit Count
- 54
- Registration Number
- NCT05291169
- Locations
- 🇺🇸
New Hope Podiatry, Los Angeles, California, United States
🇺🇸Royal Research, Corp, Hollywood, Florida, United States
🇺🇸Three Rivers Wound and Hyperbaric Center, North Port, Florida, United States
Skin Protectant Properties of Omeza Collagen Matrix on Damaged Skin
Not Applicable
Completed
- Conditions
- ErythemaTransepidermal Water Loss
- First Posted Date
- 2020-08-13
- Last Posted Date
- 2022-09-30
- Lead Sponsor
- Omeza, LLC
- Target Recruit Count
- 22
- Registration Number
- NCT04512274
- Locations
- 🇬🇧
Princeton Research Corporation, Chelmsford, Essex, United Kingdom
- Prev
- 1
- 2
- Next
News
No news found